Meetings Events & Conference Coordinators 20th Annual California Cancer Consortium Conference 2024
Meetings Events & Conference Coordinators 20th Annual California Cancer Consortium Conference 2024
Regular price
$20.00 USD
Regular price
$20.00 USD
Sale price
Unit price
per
Couldn't load pickup availability
Meetings Events & Conference Coordinators 20th Annual California Cancer Consortium Conference 2024
Regular price
$20.00
Regular price
$20.00
Sale price
Unit price
per
Meetings Events & Conference Coordinators 20th Annual California Cancer Consortium Conference 2024
Include: 27 videos, size: 1.84 GBTarget Audience: oncologists, hematologists
Information:
The 20th Annual California Cancer Consortium Conference is an event focused on advancements and updates in cancer research, treatment, and patient care. Typically, these conferences feature a range of activities, including keynote speeches, panel discussions, and presentations from leading experts in oncology.
The Medical Educator Consortium shared on X:
“Exciting News! Join us for the 20th Annual California Cancer Consortium Conference happening from August 23-25, 2024!
The Medical Educator Consortium shared on X:
“Exciting News! Join us for the 20th Annual California Cancer Consortium Conference happening from August 23-25, 2024!
The 20th Annual California Cancer Consortium Conference 2024 is designed for:
- Medical Oncologists: Professionals focusing on cancer treatment and patient care.
- Hematologists: Specialists interested in advancements in blood-related cancers.
- Healthcare Researchers: Individuals involved in cancer research and clinical trials.
- Allied Health Professionals: Those supporting oncology care and treatment.
The conference highlights advancements in cancer research, treatment strategies, and patient care.
Topics:
- Advances in Cellular Therapies for Cancer.mp4
- Advances in Limited and Extensive Stage Small Cell Lung Cancer.mp4
- Advances in Non-PD(L)1 Immunotherapies in Solid Tumors.mp4
- AML and MDS- New Directions.mp4
- Castration Resistant Prostate Cancer- What is the Optimal Strategy..mp4
- Everything You Wanted To Know About the Pitt-Cal U54 Pharmacokinetics Resource Laboratory.mp4
- Expansion Cohorts in Early Phase Clinical Trials- Valuable or Not..mp4
- HER2 Targeted Therapies- Recent Advances.mp4
- Hippo-Yap Pathway.mp4
- Hormone Therapy in Breast Cancer- New Directions.mp4
- Lymphoma- State of the Art.mp4
- Management of Renal Cell Carcinoma.mp4
- New Biomarkers in Breast Cancer.mp4
- New Developments in Esophageal and Gastric Cancer.mp4
- Novel Targets in Hematologic Malignancies.mp4
- Overview on How to Submit a Clinical Letter of Intent (LOI) to NCI-CTEP.mp4
- Perioperative Therapy and Predictive Biomarkers in Early Stage Non Small Cell Lung Cancer.mp4
- Precision Oncology and Landmark Advances in GU Malignancies.mp4
- Recent Advances in Colorectal Cancer.mp4
- State of the Art- Hormone-sensitive Prostate Cancer.mp4
- Systemic Therapy in Urothelial Carcinoma.mp4
- Targeting RAS-RAF-MAPK Pathway.mp4
- Targeting the Microbiome and Optimizing Immunotherapy in Cancer.mp4
- Updates in Immunotherapy for Metastatic Lung Cancer.mp4
- Updates in Locally Advanced Unresectable (Stage III) NSCLC.mp4
- Updates in NSCLC Targeted Therapy.mp4
- Updates in the Management of Pancreatic Cancer.mp4
